As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

India levofloxacin market is expected to grow at a steady rate during the forecast period. Surging government initiatives with an intention of increasing awareness regarding diagnosis and treatment of pneumonia and similar infections is further expected to boost the demand through FY2026. High burden of antibiotic-resistant infections is further predicted to increase the product demand in the forthcoming years, thereby bolstering the market growth.

The India levofloxacin market is segmented based on strength, application, form, route of administration, source, distribution channel, end user, company, and region. Based on form, the market is segmented into tablet, capsule and injection. The injection segment dominated the market until FY2020 and is further expected to maintain its leading position during the forecast period as it is an injectable drug which is also marketed in tablet form. This medication is given by injection into a vein as directed by your doctor, usually once a day over at least 1 hour. Also, the tablet segment is anticipated to register high growth in the next 5 years which is attributable to various factors like, safety, effectiveness and patient compliance. In addition to this, properties such as high stability of tablets are further boosting the segmental growth in the years to come.

The major players operating in the India levofloxacin market are Dr. Reddy’s Laboratories Ltd., Aden Healthcare Pvt. Ltd., Allenge India Pharmaceuticals Pvt. Ltd., Alna Biotech Pvt. Ltd., Bestochem Formulations India Ltd., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Cadila Healthcare Ltd., Valentis Pharma Pvt. Ltd., Pax Healthcare Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India levofloxacin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India levofloxacin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India levofloxacin market based on strength, application, form, route of administration, source, distribution channel, end user, company, and regional distribution.
  • To identify dominant region or segment in the India levofloxacin market.
  • To identify drivers and challenges for India levofloxacin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India levofloxacin market.
  • To identify and analyze the profile of leading players operating in India levofloxacin market.
  • To identify key sustainable strategies adopted by market players in India levofloxacin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India levofloxacin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Levofloxacin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to levofloxacin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India levofloxacin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Levofloxacin Market, By Strength:
    • 250 mg Tablets
    • 500 mg Tablets
    • 750 mg Tablets
  • India Levofloxacin Market, By Application:
    • Pneumonia
    • Skin Infection
    • Kidney Infection
    • Bladder Infection
    • Others
  • India Levofloxacin Market, By Form:
    • Tablet
    • Capsule
    • Injection
  • India Levofloxacin Market, By Route of Administration:
    • Oral
    • Intravenous
  • India Levofloxacin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Levofloxacin Market, By Distribution Channel:
    • Online
    • Offline
  • India Levofloxacin Market, By End User:
    • Adult
    • Paediatric
  • India Levofloxacin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India levofloxacin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India levofloxacin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Levofloxacin Market

4.    Executive Summary

5.    Manufacturing Levofloxacin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Levofloxacin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Levofloxacin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Strength (250 mg Tablets, 500 mg Tablets, 750 mg Tablets)

7.2.2.     By Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Others)

7.2.3.     By Form (Tablet, Capsule, Injection)

7.2.4.     By Route of Administration (Oral v/s Intravenous)

7.2.5.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.6.     By Distribution Channel (Online v/s Offline)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Dr. Reddy’s Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Aden Healthcare Pvt. Ltd.

14.1.3.  Allenge India Pharmaceuticals Pvt. Ltd.

14.1.4.  Alna Biotech Pvt. Ltd.

14.1.5.  Bestochem Formulations India Ltd.

14.1.6.  Glenmark Pharmaceuticals Ltd.

14.1.7.  Lupin Ltd.

14.1.8.  Cadila Healthcare Ltd.

14.1.9.  Valentis Pharma Pvt. Ltd.

14.1.10.                Pax Healthcare Pvt. Ltd.

15.  Strategic Recommendations

About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com